1-3 of 3
David H. Regan
Close
Sort by
Journal Articles

American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer

J. Douglas Rizzo, Melissa Brouwers, Patricia Hurley, Jerome Seidenfeld, Murat O. Arcasoy, Jerry L. Spivak, Charles L. Bennett, Julia Bohlius, Darren Evanchuk, Matthew J. Goode, Ann A. Jakubowski, David H. Regan, Mark R. Somerfield
Journal: Blood
Blood (2010) 116 (20): 4045–4059.
https://doi.org/10.1182/blood-2010-08-300541
Published: 2010
Includes: Supplemental data
Journal Articles

Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update

J. Douglas Rizzo, Mark R. Somerfield, Karen L. Hagerty, Jerome Seidenfeld, Julia Bohlius, Charles L. Bennett, David F. Cella, Benjamin Djulbegovic, Matthew J. Goode, Ann A. Jakubowski, Mark U. Rarick, David H. Regan, Alan E. Lichtin
Journal: Blood
Blood (2008) 111 (1): 25–41.
https://doi.org/10.1182/blood-2007-08-109488
Published: 2008
Journal Articles

Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology

J. Douglas Rizzo, Alan E. Lichtin, Steven H. Woolf, Jerome Seidenfeld, Charles L. Bennett, David Cella, Benjamin Djulbegovic, Matthew J. Goode, Ann A. Jakubowski, Stephanie J. Lee, Carole B. Miller, Mark U. Rarick, David H. Regan, George P. Browman, Michael S. Gordon
Journal: Blood
Blood (2002) 100 (7): 2303–2320.
https://doi.org/10.1182/blood-2002-06-1767
Published: 2002